Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Menczer

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
International Journal of Oncology|May 15, 2001
Expression of heparanase, Mdm2, and erbB2 in ovarian cancerS Ginath, J Menczer, Y Friedmann, et al.
American Journal of Epidemiology|June 10, 1998
Cancer incidence in a cohort of infertile womenB Modan, E Ron, L Lerner-Geva, et al.
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
International Journal of Oncology|May 15, 2001
Expression of heparanase, Mdm2, and erbB2 in ovarian cancerS Ginath, J Menczer, Y Friedmann, et al.
American Journal of Epidemiology|June 10, 1998
Cancer incidence in a cohort of infertile womenB Modan, E Ron, L Lerner-Geva, et al.
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Pageof 11